Skip to main content
. 2020 Jun 15;10(3):135–142.

Table 1.

Patient characteristics, n = 21

Characteristics
Age median (range) 51 (33-69)
Clinical stage (n, %)
    IIIA 6 (28.5%)
    IIIB 5 (23.8%)
    IIIC 4 (19.2%)
    IV 6 (28.5%)
Breast cancer subtype
    LUM A (n, %) 4, 19%
    LUM B HER2- (n, %) 4, 19%
    LUM B HER-2+ (n, %) 2, 9.5%
    HER-2 overexpression (n, %) 6, 28.5%
    TPN (n, %) 5, 24%

Abbreviations: LUM = molecular subtypes of breast cancer including luminal A and luminal B; HER-2 = human epidermal growth factor receptor 2; TPN = triple negative breast cancer.